Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/TRAWS-PHARMA-INC-46372025/news/Onconova-Therapeutics-Preclinical-Narazaciclib-Data-at-SABCS-Highlights-Differentiated-Anti-Tumor-A-45535993/?utm_source=whatsapp&utm_medium=social&utm_campaign=share